UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000031216 |
|---|---|
| Receipt number | R000035466 |
| Scientific Title | A Prospective, Multicenter, Observational Study in Relapsed and/or Refractory Multiple Myeloma Patients Treated with Ixazomib plus Lenalidomide and Dexamethasone |
| Date of disclosure of the study information | 2018/02/09 |
| Last modified on | 2025/11/11 15:30:07 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2018/02/09 09:58:02 | ||
| 2 | Update | 2018/02/16 16:46:24 | Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 Study ID_2 Org. issuing International ID_2 Org. issuing International ID_2 |
|
| 3 | Update | 2018/04/03 12:40:15 | Recruitment status Anticipated trial start date |
|
| 4 | Update | 2018/07/18 10:07:43 | Last follow-up date |
|
| 5 | Update | 2019/02/13 10:10:51 | Last follow-up date |
|
| 6 | Update | 2019/03/07 10:43:22 | Division name Division name Address Address Division name Division name Address Address |
|
| 7 | Update | 2019/07/01 15:09:18 | Recruitment status Date of IRB |
|
| 8 | Update | 2025/11/11 11:56:51 | 1st name of lead principal investigator 1st name of lead principal investigator Zip code Zip code Name of person sending information Name of person sending information Email1 Organization Organization Address Address Tel |
|
| 9 | Update | 2025/11/11 12:00:30 | Recruitment status |
|
| 10 | Update | 2025/11/11 15:30:07 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
